Guardant Health (GH) Depreciation and Depletion (2017 - 2026)

Guardant Health has disclosed Depreciation and Depletion across 10 years of filings, most recently posting $9.1 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $9.1 million, down 7.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.4 million (down 6.27% YoY), and the FY2025 annual result was $38.1 million, down 4.99% from the prior year.
• Depreciation and Depletion came in at $9.1 million for Q1 2026 at Guardant Health, down from $9.7 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $10.3 million in Q3 2023 to a low of $6.7 million in Q1 2022.
• The 5-year median for Depreciation and Depletion is $9.7 million (2025), against an average of $9.4 million.
• Across the five-year window, Depreciation and Depletion jumped 82.0% in 2022 and dropped 10.89% in 2025, its largest moves.
• Guardant Health's Depreciation and Depletion stood at $9.5 million in 2022, then rose by 6.32% to $10.1 million in 2023, then retreated by 1.98% to $9.9 million in 2024, then dropped by 2.02% to $9.7 million in 2025, then declined by 6.19% to $9.1 million in 2026.
• The last three Depreciation and Depletion figures came in at $9.1 million (Q1 2026), $9.7 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.